MYC and cancer: This β-catenin transfer resulted in heightened expression of active β-catenin and oncoproteins that positively regulates cancer stemness (c-Myc, OCT4, SOX2), amplifying malignant phenotypes such as radioresistance and CSC activity in recipient cells.